Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CRYZ | Human | (+)-schisandrin B | multiple interactions | ISO | Cryz (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CRYZ mRNA] | CTD | PMID:31150632 | CRYZ | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CRYZ mRNA | CTD | PMID:36331819 | CRYZ | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CRYZ mRNA | CTD | PMID:22206623 | CRYZ | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Cryz (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CRYZ mRNA | CTD | PMID:22206623 | CRYZ | Human | 17beta-estradiol | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | [Polyphenols co-treated with Estradiol] results in increased expression of CRYZ mRNA | CTD | PMID:30077407 | CRYZ | Human | 2,2,2-tetramine | multiple interactions | ISO | Cryz (Rattus norvegicus) | 6480464 | Trientine inhibits the reaction [Streptozocin results in decreased expression of CRYZ protein] | CTD | PMID:19634143 | CRYZ | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CRYZ mRNA | CTD | PMID:12377990 | CRYZ | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CRYZ mRNA | CTD | PMID:33387578 | CRYZ | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cryz (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CRYZ mRNA | CTD | PMID:21570461 | CRYZ | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CRYZ mRNA | CTD | PMID:21215274 | CRYZ | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cryz (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CRYZ mRNA | CTD | PMID:15297030 | CRYZ | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | Cryz (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CRYZ protein | CTD | PMID:15297030 | CRYZ | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CRYZ protein] more ... | CTD | PMID:15297030 | CRYZ | Human | 2,4,6-tribromophenol | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31675489 | CRYZ | Human | 2,4-dinitrotoluene | affects expression | ISO | Cryz (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of CRYZ mRNA | CTD | PMID:21346803 | CRYZ | Human | 2,5-dihydroxybenzoic acid | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | 2 and 5-dihydroxybenzoic acid inhibits the reaction [Benzoyl Peroxide results in decreased activity of CRYZ protein] | CTD | PMID:15454305 | CRYZ | Human | 2-hydroxypropanoic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of CRYZ mRNA | CTD | PMID:30851411 | CRYZ | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of CRYZ mRNA | CTD | PMID:21179406 | CRYZ | Human | 3,3',5,5'-tetrabromobisphenol A | decreases expression | EXP | | 6480464 | tetrabromobisphenol A results in decreased expression of CRYZ protein | CTD | PMID:31675489 | CRYZ | Human | 3-methylcholanthrene | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | AHR protein promotes the reaction [Methylcholanthrene results in increased activity of CRYZ protein] more ... | CTD | PMID:15297030 | CRYZ | Human | 3-methylcholanthrene | increases activity | ISO | Cryz (Rattus norvegicus) | 6480464 | Methylcholanthrene results in increased activity of CRYZ protein | CTD | PMID:19788401 | CRYZ | Human | 3-methylcholanthrene | multiple interactions | ISO | Cryz (Rattus norvegicus) | 6480464 | sanguinarine inhibits the reaction [Methylcholanthrene results in increased activity of CRYZ protein] | CTD | PMID:19788401 | CRYZ | Human | 3-methylcholanthrene | increases expression | ISO | Cryz (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of CRYZ mRNA | CTD | PMID:15297030 | CRYZ | Human | 3-methylcholanthrene | increases activity | ISO | Cryz (Mus musculus) | 6480464 | Methylcholanthrene results in increased activity of CRYZ protein | CTD | PMID:15297030 | CRYZ | Human | 3H-1,2-dithiole-3-thione | increases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | 1 and 2-dithiol-3-thione results in increased expression of CRYZ | CTD | PMID:7563217 | CRYZ | Human | 3H-1,2-dithiole-3-thione | increases expression | ISO | Cryz (Mus musculus) | 6480464 | 1 and 2-dithiol-3-thione results in increased expression of CRYZ | CTD | PMID:7563217 | CRYZ | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of CRYZ protein | CTD | PMID:34186270 | CRYZ | Human | 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CRYZ mRNA | CTD | PMID:12419474 | CRYZ | Human | 4-nitroquinoline N-oxide | increases activity | ISO | Cryz (Rattus norvegicus) | 6480464 | 4-Nitroquinoline-1-oxide results in increased activity of CRYZ protein | CTD | PMID:12566915 | CRYZ | Human | 4-nitroquinoline N-oxide | multiple interactions | ISO | Cryz (Rattus norvegicus) | 6480464 | ethyl-3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CRYZ protein] | CTD | PMID:12566915 | CRYZ | Human | 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of CRYZ mRNA | CTD | PMID:17982676 | CRYZ | Human | 5-fluorouracil | multiple interactions | EXP | | 6480464 | TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of CRYZ mRNA] | CTD | PMID:17982676 | CRYZ | Human | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of CRYZ protein | CTD | PMID:20106945 | CRYZ | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of CRYZ gene | CTD | PMID:27153756 | CRYZ | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CRYZ mRNA | CTD | PMID:33167477 | CRYZ | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of CRYZ protein | CTD | PMID:33212167 | CRYZ | Human | benzatropine | multiple interactions | EXP | | 6480464 | [Cuprizone co-treated with Benztropine] results in decreased expression of CRYZ protein | CTD | PMID:34122009 | CRYZ | Human | benzo[a]pyrene | increases activity | ISO | Cryz (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased activity of CRYZ protein | CTD | PMID:15297030 | CRYZ | Human | benzo[a]pyrene | decreases activity | ISO | Cryz (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased activity of CRYZ protein | CTD | PMID:29019276 | CRYZ | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CRYZ mRNA | CTD | PMID:32234424 | CRYZ | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of CRYZ promoter | CTD | PMID:27901495 | CRYZ | Human | benzo[a]pyrene | increases expression | ISO | Cryz (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CRYZ mRNA | CTD | PMID:15297030 and PMID:22228805 | CRYZ | Human | benzo[a]pyrene | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CRYZ mRNA] more ... | CTD | PMID:15297030 more ... | CRYZ | Human | Benzoyl peroxide | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:12804013 more ... | CRYZ | Human | Benzoyl peroxide | affects activity | ISO | Cryz (Mus musculus) | 6480464 | Benzoyl Peroxide affects the activity of CRYZ protein | CTD | PMID:15248479 | CRYZ | Human | Benzoyl peroxide | decreases activity | ISO | Cryz (Mus musculus) | 6480464 | Benzoyl Peroxide results in decreased activity of CRYZ protein | CTD | PMID:12804013 more ... | CRYZ | Human | beta-ionone | increases activity | ISO | Cryz (Mus musculus) | 6480464 | beta-ionone results in increased activity of CRYZ protein | CTD | PMID:31506784 | CRYZ | Human | beta-naphthoflavone | increases activity | ISO | Cryz (Mus musculus) | 6480464 | beta-Naphthoflavone results in increased activity of CRYZ protein | CTD | PMID:15297030 | CRYZ | Human | beta-naphthoflavone | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | AHR protein promotes the reaction [beta-Naphthoflavone results in increased activity of CRYZ protein] more ... | CTD | PMID:15297030 | CRYZ | Human | beta-naphthoflavone | increases expression | ISO | Cryz (Mus musculus) | 6480464 | beta-Naphthoflavone results in increased expression of CRYZ mRNA | CTD | PMID:15297030 | CRYZ | Human | bisphenol A | decreases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CRYZ mRNA | CTD | PMID:25181051 more ... | CRYZ | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CRYZ protein | CTD | PMID:31675489 | CRYZ | Human | bisphenol A | increases methylation | ISO | Cryz (Mus musculus) | 6480464 | bisphenol A results in increased methylation of CRYZ promoter | CTD | PMID:27312807 | CRYZ | Human | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of CRYZ protein | CTD | PMID:34186270 | CRYZ | Human | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of CRYZ protein | CTD | PMID:34186270 | CRYZ | Human | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of CRYZ protein | CTD | PMID:24527689 | CRYZ | Human | cannabidiol | increases expression | EXP | | 6480464 | Cannabidiol results in increased expression of CRYZ protein | CTD | PMID:34122009 | CRYZ | Human | carvacrol | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | carvacrol inhibits the reaction [Benzo(a)pyrene results in decreased activity of CRYZ protein] | CTD | PMID:29019276 | CRYZ | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CRYZ gene] | CTD | PMID:28238834 | CRYZ | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CRYZ mRNA | CTD | PMID:19376846 | CRYZ | Human | cobalt dichloride | decreases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | cobaltous chloride results in decreased expression of CRYZ mRNA | CTD | PMID:24386269 | CRYZ | Human | copper atom | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | Copper inhibits the reaction [Benzo(a)pyrene results in increased expression of CRYZ mRNA] more ... | CTD | PMID:15297030 | CRYZ | Human | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CRYZ mRNA | CTD | PMID:20971185 | CRYZ | Human | copper atom | increases activity | ISO | Cryz (Mus musculus) | 6480464 | Copper results in increased activity of CRYZ protein | CTD | PMID:15297030 | CRYZ | Human | copper(0) | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | Copper inhibits the reaction [Benzo(a)pyrene results in increased expression of CRYZ mRNA] more ... | CTD | PMID:15297030 | CRYZ | Human | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CRYZ mRNA | CTD | PMID:20971185 | CRYZ | Human | copper(0) | increases activity | ISO | Cryz (Mus musculus) | 6480464 | Copper results in increased activity of CRYZ protein | CTD | PMID:15297030 | CRYZ | Human | Cuprizon | increases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of CRYZ mRNA | CTD | PMID:26577399 | CRYZ | Human | Cuprizon | multiple interactions | EXP | | 6480464 | [Cuprizone co-treated with Benztropine] results in decreased expression of CRYZ protein | CTD | PMID:34122009 | CRYZ | Human | cycloartenol | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | cycloartenol inhibits the reaction [Benzoyl Peroxide results in decreased activity of CRYZ protein] | CTD | PMID:12804013 | CRYZ | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CRYZ mRNA | CTD | PMID:20106945 and PMID:22147139 | CRYZ | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of CRYZ mRNA | CTD | PMID:28302478 | CRYZ | Human | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of CRYZ mRNA | CTD | PMID:29803840 | CRYZ | Human | endosulfan | decreases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of CRYZ mRNA | CTD | PMID:29391264 | CRYZ | Human | epoxiconazole | decreases expression | ISO | Cryz (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of CRYZ mRNA | CTD | PMID:35436446 | CRYZ | Human | flutamide | decreases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of CRYZ mRNA | CTD | PMID:24793618 | CRYZ | Human | folic acid | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CRYZ mRNA | CTD | PMID:22206623 | CRYZ | Human | formaldehyde | increases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | Formaldehyde results in increased expression of CRYZ mRNA | CTD | PMID:12679049 | CRYZ | Human | gentamycin | decreases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of CRYZ mRNA | CTD | PMID:22061828 and PMID:33387578 | CRYZ | Human | glafenine | decreases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | Glafenine results in decreased expression of CRYZ mRNA | CTD | PMID:24136188 | CRYZ | Human | glyphosate | increases methylation | ISO | Cryz (Rattus norvegicus) | 6480464 | Glyphosate results in increased methylation of CRYZ gene | CTD | PMID:31011160 | CRYZ | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of CRYZ mRNA | CTD | PMID:20044591 | CRYZ | Human | inulin | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CRYZ mRNA | CTD | PMID:36331819 | CRYZ | Human | isotretinoin | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | Isotretinoin inhibits the reaction [Benzoyl Peroxide results in decreased activity of CRYZ protein] | CTD | PMID:15225900 | CRYZ | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of CRYZ protein | CTD | PMID:32959892 | CRYZ | Human | lead(0) | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | AHR protein promotes the reaction [Lead results in increased activity of CRYZ protein] more ... | CTD | PMID:15297030 | CRYZ | Human | lead(0) | increases activity | ISO | Cryz (Mus musculus) | 6480464 | Lead results in increased activity of CRYZ protein | CTD | PMID:15297030 | CRYZ | Human | lupeol | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | lupeol inhibits the reaction [Benzoyl Peroxide affects the activity of CRYZ protein] | CTD | PMID:15248479 | CRYZ | Human | mercury atom | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | Mercury promotes the reaction [Benzo(a)pyrene results in increased activity of CRYZ protein] more ... | CTD | PMID:15297030 | CRYZ | Human | mercury atom | increases activity | ISO | Cryz (Mus musculus) | 6480464 | Mercury results in increased activity of CRYZ protein | CTD | PMID:15297030 | CRYZ | Human | mercury(0) | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | Mercury promotes the reaction [Benzo(a)pyrene results in increased activity of CRYZ protein] more ... | CTD | PMID:15297030 | CRYZ | Human | mercury(0) | increases activity | ISO | Cryz (Mus musculus) | 6480464 | Mercury results in increased activity of CRYZ protein | CTD | PMID:15297030 | CRYZ | Human | methidathion | increases expression | ISO | Cryz (Mus musculus) | 6480464 | methidathion results in increased expression of CRYZ mRNA | CTD | PMID:34813904 | CRYZ | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of CRYZ mRNA | CTD | PMID:28001369 | CRYZ | Human | Monobutylphthalate | increases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | monobutyl phthalate results in increased expression of CRYZ mRNA | CTD | PMID:29162477 | CRYZ | Human | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | decreases expression | EXP | | 6480464 | N more ... | CTD | PMID:12888634 | CRYZ | Human | paracetamol | affects expression | ISO | Cryz (Mus musculus) | 6480464 | Acetaminophen affects the expression of CRYZ mRNA | CTD | PMID:17562736 | CRYZ | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CRYZ mRNA | CTD | PMID:21420995 and PMID:29067470 | CRYZ | Human | parathion | increases expression | ISO | Cryz (Mus musculus) | 6480464 | Parathion results in increased expression of CRYZ mRNA | CTD | PMID:34813904 | CRYZ | Human | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CRYZ mRNA | CTD | PMID:27153767 | CRYZ | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cryz (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CRYZ mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CRYZ mRNA | CTD | PMID:36331819 | CRYZ | Human | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of CRYZ mRNA | CTD | PMID:19159669 | CRYZ | Human | picoxystrobin | increases expression | EXP | | 6480464 | picoxystrobin results in increased expression of CRYZ mRNA | CTD | PMID:33512557 | CRYZ | Human | propiconazole | decreases expression | ISO | Cryz (Mus musculus) | 6480464 | propiconazole results in decreased expression of CRYZ mRNA | CTD | PMID:21278054 | CRYZ | Human | quercetin | increases activity | ISO | Cryz (Mus musculus) | 6480464 | Quercetin results in increased activity of CRYZ protein | CTD | PMID:8968052 | CRYZ | Human | quercetin 4'-O-beta-D-glucopyranoside | increases activity | ISO | Cryz (Mus musculus) | 6480464 | spiraeoside results in increased activity of CRYZ protein | CTD | PMID:8968052 | CRYZ | Human | rac-lactic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of CRYZ mRNA | CTD | PMID:30851411 | CRYZ | Human | resveratrol | increases expression | ISO | Cryz (Mus musculus) | 6480464 | resveratrol results in increased expression of CRYZ mRNA | CTD | PMID:22610192 | CRYZ | Human | resveratrol | affects expression | ISO | Cryz (Rattus norvegicus) | 6480464 | resveratrol affects the expression of CRYZ mRNA | CTD | PMID:15748624 | CRYZ | Human | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of CRYZ mRNA | CTD | PMID:33512557 | CRYZ | Human | sanguinarine | decreases activity | ISO | Cryz (Rattus norvegicus) | 6480464 | sanguinarine results in decreased activity of CRYZ protein | CTD | PMID:19788401 | CRYZ | Human | sanguinarine | multiple interactions | ISO | Cryz (Rattus norvegicus) | 6480464 | sanguinarine inhibits the reaction [Methylcholanthrene results in increased activity of CRYZ protein] | CTD | PMID:19788401 | CRYZ | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CRYZ protein | CTD | PMID:37664457 | CRYZ | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of CRYZ mRNA | CTD | PMID:29301061 | CRYZ | Human | streptozocin | decreases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | Streptozocin results in decreased expression of CRYZ protein | CTD | PMID:19634143 | CRYZ | Human | streptozocin | multiple interactions | ISO | Cryz (Rattus norvegicus) | 6480464 | Trientine inhibits the reaction [Streptozocin results in decreased expression of CRYZ protein] | CTD | PMID:19634143 | CRYZ | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of CRYZ mRNA | CTD | PMID:31533062 | CRYZ | Human | tert-butyl hydroperoxide | decreases response to substance | ISO | Cryz (Mus musculus) | 6480464 | CRYZ protein results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:15003993 | CRYZ | Human | tert-butyl hydroperoxide | increases expression | ISO | Cryz (Mus musculus) | 6480464 | tert-Butylhydroperoxide results in increased expression of CRYZ mRNA | CTD | PMID:14729362 more ... | CRYZ | Human | tetrachloromethane | decreases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of CRYZ mRNA | CTD | PMID:31150632 | CRYZ | Human | tetrachloromethane | decreases expression | ISO | Cryz (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of CRYZ mRNA | CTD | PMID:31919559 | CRYZ | Human | tetrachloromethane | multiple interactions | ISO | Cryz (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CRYZ mRNA] | CTD | PMID:31150632 | CRYZ | Human | tetrahydropalmatine | decreases expression | EXP | | 6480464 | tetrahydropalmatine results in decreased expression of CRYZ protein | CTD | PMID:20109541 | CRYZ | Human | thapsigargin | multiple interactions | EXP | | 6480464 | Drugs and Chinese Herbal promotes the reaction [Thapsigargin results in increased expression of CRYZ mRNA] | CTD | PMID:19442820 | CRYZ | Human | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of CRYZ mRNA | CTD | PMID:22378314 | CRYZ | Human | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of CRYZ mRNA | CTD | PMID:19442820 | CRYZ | Human | thioacetamide | decreases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of CRYZ mRNA | CTD | PMID:34492290 | CRYZ | Human | valdecoxib | decreases expression | ISO | Cryz (Rattus norvegicus) | 6480464 | valdecoxib results in decreased expression of CRYZ mRNA | CTD | PMID:24136188 | CRYZ | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CRYZ mRNA | CTD | PMID:29154799 | CRYZ | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CRYZ mRNA | CTD | PMID:19101580 and PMID:28001369 | CRYZ | Human | xanthohumol | increases activity | ISO | Cryz (Mus musculus) | 6480464 | xanthohumol results in increased activity of CRYZ protein | CTD | PMID:17590382 | CRYZ | Human | zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of CRYZ mRNA | CTD | PMID:22171008 | CRYZ | Human | zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of CRYZ mRNA | CTD | PMID:22171008 | |